US Stock MarketDetailed Quotes

VMD Viemed Healthcare

Watchlist
  • 8.080
  • -0.050-0.62%
Trading Dec 19 11:42 ET
314.61MMarket Cap32.32P/E (TTM)

Viemed Healthcare Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
17.41%58M
26.91%54.97M
27.90%50.59M
31.82%183.01M
35.28%50.74M
38.15%49.4M
30.02%43.31M
22.64%39.56M
18.60%138.83M
17.35%37.51M
Operating revenue
17.41%58M
26.91%54.97M
27.90%50.59M
31.82%183.01M
35.28%50.74M
38.15%49.4M
30.02%43.31M
22.64%39.56M
18.60%138.83M
17.35%37.51M
Cost of revenue
25.44%23.63M
28.29%22.07M
33.69%20.79M
29.68%70.23M
27.48%18.63M
33.54%18.84M
33.17%17.21M
24.30%15.55M
24.05%54.15M
18.80%14.61M
Gross profit
12.46%34.37M
25.99%32.89M
24.15%29.8M
33.19%112.78M
40.25%32.11M
41.16%30.56M
28.03%26.11M
21.58%24M
15.35%84.68M
16.45%22.9M
Operating expense
12.02%29.21M
29.16%29.82M
23.96%27.39M
28.56%97.81M
38.40%26.55M
31.11%26.08M
18.41%23.09M
26.18%22.09M
23.95%76.08M
29.16%19.18M
Selling and administrative expenses
13.05%28.38M
27.63%28.12M
24.08%26.25M
27.77%93.73M
37.59%25.44M
32.24%25.11M
17.16%22.03M
23.84%21.15M
22.18%73.36M
18.94%18.49M
-General and administrative expense
13.05%28.38M
27.63%28.12M
24.08%26.25M
27.77%93.73M
37.59%25.44M
32.24%25.11M
17.16%22.03M
23.84%21.15M
22.18%73.36M
18.94%18.49M
Research and development costs
27.66%757K
0.00%758K
-3.85%750K
3.19%2.78M
-9.83%651K
-11.49%593K
12.80%758K
23.42%780K
27.77%2.7M
17.97%722K
Depreciation amortization depletion
-16.95%348K
26.51%377K
72.92%415K
37.45%1.39M
80.08%434K
43.99%419K
22.63%298K
1.27%240K
18.92%1.01M
3.43%241K
-Depreciation and amortization
-16.95%348K
26.51%377K
72.92%415K
37.45%1.39M
80.08%434K
43.99%419K
22.63%298K
1.27%240K
18.92%1.01M
3.43%241K
Other operating expenses
-573.17%-276K
28,250.00%563K
67.90%-26K
90.09%-98K
109.70%26K
28.07%-41K
99.10%-2K
81.63%-81K
39.03%-989K
82.56%-268K
Operating profit
15.05%5.16M
1.76%3.07M
26.41%2.42M
74.17%14.98M
49.81%5.56M
154.63%4.48M
238.72%3.02M
-14.41%1.91M
-28.52%8.6M
-22.81%3.71M
Net non-operating interest income expense
5.06%-225K
-1,370.00%-254K
-406.12%-150K
-115.23%-424K
-700.00%-256K
-464.29%-237K
133.90%20K
176.56%49K
38.05%-197K
53.62%-32K
Non-operating interest income
----
----
----
----
----
----
----
--49K
----
----
Non-operating interest expense
-5.06%225K
----
--150K
115.23%424K
700.00%256K
464.29%237K
----
----
-38.05%197K
-53.62%32K
Total other finance cost
----
1,370.00%254K
----
----
----
----
-133.90%-20K
----
----
----
Other net income (expense)
7,162.50%565K
-2,960.00%-572K
-356.14%-146K
-127.16%-160K
-138.54%-229K
96.15%-8K
-96.40%20K
-83.09%57K
-25.73%589K
-130.48%-96K
Earnings from equity interest
-64.44%96K
-915.33%-1.12M
91.43%67K
-48.13%485K
-47.56%43K
221.43%270K
-69.28%137K
-89.16%35K
-24.66%935K
-82.14%82K
Special income (charges)
268.71%469K
565.81%545K
-1,068.18%-213K
-86.42%-645K
-52.81%-272K
4.79%-278K
-206.36%-117K
57.14%22K
22.77%-346K
-23.61%-178K
-Gain on sale of property,plant,equipment
268.71%469K
565.81%545K
-1,068.18%-213K
-86.42%-645K
-52.81%-272K
4.79%-278K
-206.36%-117K
57.14%22K
22.77%-346K
-23.61%-178K
Income before tax
29.72%5.5M
-26.59%2.25M
5.10%2.12M
60.08%14.39M
41.63%5.08M
180.54%4.24M
120.32%3.06M
-19.51%2.02M
-28.10%8.99M
-29.10%3.58M
Income tax
20.76%1.59M
5.49%768K
3.39%518K
49.86%4.15M
39.53%1.6M
189.47%1.32M
72.92%728K
-32.75%501K
-18.03%2.77M
18.39%1.15M
Net income
33.78%3.91M
-36.61%1.48M
5.67%1.6M
64.63%10.24M
42.62%3.48M
176.68%2.92M
140.95%2.33M
-13.90%1.52M
-31.82%6.22M
-40.35%2.44M
Net income continuous Operations
33.78%3.91M
-36.61%1.48M
5.67%1.6M
64.63%10.24M
42.62%3.48M
176.68%2.92M
140.95%2.33M
-13.90%1.52M
-31.82%6.22M
-40.35%2.44M
Minority interest income
27K
9K
0
0
Net income attributable to the parent company
32.85%3.88M
-37.00%1.47M
5.67%1.6M
64.63%10.24M
42.62%3.48M
176.68%2.92M
140.95%2.33M
-13.90%1.52M
-31.82%6.22M
-40.35%2.44M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
32.85%3.88M
-37.00%1.47M
5.67%1.6M
64.63%10.24M
42.62%3.48M
176.68%2.92M
140.95%2.33M
-13.90%1.52M
-31.82%6.22M
-40.35%2.44M
Basic earnings per share
25.00%0.1
-33.33%0.04
0.00%0.04
68.75%0.27
50.00%0.09
166.67%0.08
200.00%0.06
0.00%0.04
-30.43%0.16
-40.00%0.06
Diluted earnings per share
42.86%0.1
-33.33%0.04
0.00%0.04
56.25%0.25
33.33%0.08
133.33%0.07
200.00%0.06
0.00%0.04
-27.27%0.16
-40.00%0.06
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
--
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 17.41%58M26.91%54.97M27.90%50.59M31.82%183.01M35.28%50.74M38.15%49.4M30.02%43.31M22.64%39.56M18.60%138.83M17.35%37.51M
Operating revenue 17.41%58M26.91%54.97M27.90%50.59M31.82%183.01M35.28%50.74M38.15%49.4M30.02%43.31M22.64%39.56M18.60%138.83M17.35%37.51M
Cost of revenue 25.44%23.63M28.29%22.07M33.69%20.79M29.68%70.23M27.48%18.63M33.54%18.84M33.17%17.21M24.30%15.55M24.05%54.15M18.80%14.61M
Gross profit 12.46%34.37M25.99%32.89M24.15%29.8M33.19%112.78M40.25%32.11M41.16%30.56M28.03%26.11M21.58%24M15.35%84.68M16.45%22.9M
Operating expense 12.02%29.21M29.16%29.82M23.96%27.39M28.56%97.81M38.40%26.55M31.11%26.08M18.41%23.09M26.18%22.09M23.95%76.08M29.16%19.18M
Selling and administrative expenses 13.05%28.38M27.63%28.12M24.08%26.25M27.77%93.73M37.59%25.44M32.24%25.11M17.16%22.03M23.84%21.15M22.18%73.36M18.94%18.49M
-General and administrative expense 13.05%28.38M27.63%28.12M24.08%26.25M27.77%93.73M37.59%25.44M32.24%25.11M17.16%22.03M23.84%21.15M22.18%73.36M18.94%18.49M
Research and development costs 27.66%757K0.00%758K-3.85%750K3.19%2.78M-9.83%651K-11.49%593K12.80%758K23.42%780K27.77%2.7M17.97%722K
Depreciation amortization depletion -16.95%348K26.51%377K72.92%415K37.45%1.39M80.08%434K43.99%419K22.63%298K1.27%240K18.92%1.01M3.43%241K
-Depreciation and amortization -16.95%348K26.51%377K72.92%415K37.45%1.39M80.08%434K43.99%419K22.63%298K1.27%240K18.92%1.01M3.43%241K
Other operating expenses -573.17%-276K28,250.00%563K67.90%-26K90.09%-98K109.70%26K28.07%-41K99.10%-2K81.63%-81K39.03%-989K82.56%-268K
Operating profit 15.05%5.16M1.76%3.07M26.41%2.42M74.17%14.98M49.81%5.56M154.63%4.48M238.72%3.02M-14.41%1.91M-28.52%8.6M-22.81%3.71M
Net non-operating interest income expense 5.06%-225K-1,370.00%-254K-406.12%-150K-115.23%-424K-700.00%-256K-464.29%-237K133.90%20K176.56%49K38.05%-197K53.62%-32K
Non-operating interest income ------------------------------49K--------
Non-operating interest expense -5.06%225K------150K115.23%424K700.00%256K464.29%237K---------38.05%197K-53.62%32K
Total other finance cost ----1,370.00%254K-----------------133.90%-20K------------
Other net income (expense) 7,162.50%565K-2,960.00%-572K-356.14%-146K-127.16%-160K-138.54%-229K96.15%-8K-96.40%20K-83.09%57K-25.73%589K-130.48%-96K
Earnings from equity interest -64.44%96K-915.33%-1.12M91.43%67K-48.13%485K-47.56%43K221.43%270K-69.28%137K-89.16%35K-24.66%935K-82.14%82K
Special income (charges) 268.71%469K565.81%545K-1,068.18%-213K-86.42%-645K-52.81%-272K4.79%-278K-206.36%-117K57.14%22K22.77%-346K-23.61%-178K
-Gain on sale of property,plant,equipment 268.71%469K565.81%545K-1,068.18%-213K-86.42%-645K-52.81%-272K4.79%-278K-206.36%-117K57.14%22K22.77%-346K-23.61%-178K
Income before tax 29.72%5.5M-26.59%2.25M5.10%2.12M60.08%14.39M41.63%5.08M180.54%4.24M120.32%3.06M-19.51%2.02M-28.10%8.99M-29.10%3.58M
Income tax 20.76%1.59M5.49%768K3.39%518K49.86%4.15M39.53%1.6M189.47%1.32M72.92%728K-32.75%501K-18.03%2.77M18.39%1.15M
Net income 33.78%3.91M-36.61%1.48M5.67%1.6M64.63%10.24M42.62%3.48M176.68%2.92M140.95%2.33M-13.90%1.52M-31.82%6.22M-40.35%2.44M
Net income continuous Operations 33.78%3.91M-36.61%1.48M5.67%1.6M64.63%10.24M42.62%3.48M176.68%2.92M140.95%2.33M-13.90%1.52M-31.82%6.22M-40.35%2.44M
Minority interest income 27K9K00
Net income attributable to the parent company 32.85%3.88M-37.00%1.47M5.67%1.6M64.63%10.24M42.62%3.48M176.68%2.92M140.95%2.33M-13.90%1.52M-31.82%6.22M-40.35%2.44M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 32.85%3.88M-37.00%1.47M5.67%1.6M64.63%10.24M42.62%3.48M176.68%2.92M140.95%2.33M-13.90%1.52M-31.82%6.22M-40.35%2.44M
Basic earnings per share 25.00%0.1-33.33%0.040.00%0.0468.75%0.2750.00%0.09166.67%0.08200.00%0.060.00%0.04-30.43%0.16-40.00%0.06
Diluted earnings per share 42.86%0.1-33.33%0.040.00%0.0456.25%0.2533.33%0.08133.33%0.07200.00%0.060.00%0.04-27.27%0.16-40.00%0.06
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion------------
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Oracle
ORCL
+2.97%
Amazon
AMZN
+2.29%
Adobe
ADBE
+1.57%
Meta Platforms
META
+1.60%
Petroleo Brasileiro SA Petrobras
PBR
+1.60%

Unlock the Full List